Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsa Kalbacher

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Clinical Drug Investigation|September 26, 2016
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal TumorsVirginie Nerich, Camille Fleck, Loïc Chaigneau, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2012
Specific anticancer treatments in the last 3 months of life: a French experienceErika Viel, Loïc Chaigneau, Eleonor Fanton, et al.
Critical Care (London, England)|February 10, 2021
Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validationRomain Chopard, David Jimenez, Guillaume Serzian, et al.
Bulletin Du Cancer|January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of advanced cervical cancer]Renaud Sabatier, Christophe Hennequin, Jérôme Martin-Babau, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian CancerLaura Mansi, Martin Demarchi, Fernando Bazan, et al.
Rare Tumors|November 9, 2011
Efficacy of trabectedin in metastatic solitary fibrous tumorLoïc Chaigneau, Elsa Kalbacher, Antoine Thiery-Vuillemin, et al.
Bulletin Du Cancer|August 12, 2023
Alejandra Martínez, Cyrus Chargari, Elsa Kalbacher, et al.
Anti-Cancer Drugs|September 22, 2010
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumorsAntoine Thiery-Vuillemin, Erion Dobi, Thierry Nguyen, et al.
Molecular Oncology|June 26, 2024
Endometrioid ovarian carcinoma landscape: pathological and molecular characterizationAlexandre de Nonneville, Elsa Kalbacher, Francesco Cannone, et al.
Archives of Cardiovascular Diseases|November 7, 2019
Clinical patterns and significance of non-compliance with guideline-recommended treatment of acute pulmonary embolismLisbeth Cart, Guillaume Serzian, Sébastien Humbert, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Clinical Drug Investigation|September 26, 2016
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal TumorsVirginie Nerich, Camille Fleck, Loïc Chaigneau, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2012
Specific anticancer treatments in the last 3 months of life: a French experienceErika Viel, Loïc Chaigneau, Eleonor Fanton, et al.
Critical Care (London, England)|February 10, 2021
Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validationRomain Chopard, David Jimenez, Guillaume Serzian, et al.
Bulletin Du Cancer|January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of advanced cervical cancer]Renaud Sabatier, Christophe Hennequin, Jérôme Martin-Babau, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian CancerLaura Mansi, Martin Demarchi, Fernando Bazan, et al.
Rare Tumors|November 9, 2011
Efficacy of trabectedin in metastatic solitary fibrous tumorLoïc Chaigneau, Elsa Kalbacher, Antoine Thiery-Vuillemin, et al.
Bulletin Du Cancer|August 12, 2023
Alejandra Martínez, Cyrus Chargari, Elsa Kalbacher, et al.
Anti-Cancer Drugs|September 22, 2010
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumorsAntoine Thiery-Vuillemin, Erion Dobi, Thierry Nguyen, et al.
Molecular Oncology|June 26, 2024
Endometrioid ovarian carcinoma landscape: pathological and molecular characterizationAlexandre de Nonneville, Elsa Kalbacher, Francesco Cannone, et al.
Archives of Cardiovascular Diseases|November 7, 2019
Clinical patterns and significance of non-compliance with guideline-recommended treatment of acute pulmonary embolismLisbeth Cart, Guillaume Serzian, Sébastien Humbert, et al.
Pageof 6